Central centrifugal cicatricial alopecia pathogenesis studied

September 21, 2012
Central centrifugal cicatricial alopecia pathogenesis studied
Protease-activated receptor 2, which is activated by cowhage, may play a role in central centrifugal cicatricial alopecia, the most common cause of scarring hair loss in African-American women, according to research published online Sept. 17 in the British Journal of Dermatology.

(HealthDay)—Protease-activated receptor 2 (PAR-2), which is activated by cowhage, may play a role in central centrifugal cicatricial alopecia (CCCA), the most common cause of scarring hair loss in African-American women, according to research published online Sept. 17 in the British Journal of Dermatology.

To investigate the neural component of CCCA, Ghada A. Bin Saif, M.D., of the King Saud University in Riyadh, Saudi Arabia, and colleagues conducted a study involving 15 healthy African-American women and 16 African-American women with CCCA. All women underwent computerized thermosensory testing to assess warmth and heat pain thresholds. The intensity of itching was assessed following histamine iontophoresis and the application of cowhage spicules, which activates PAR-2.

The researchers found that CCCA severity correlated significantly with peak itch ratings following cowhage, but not histamine, application to the lesional scalp of women with CCCA. In both healthy women and those with CCCA, warmth and pain thresholds were higher on the crown than the occiput.

"Our results suggest a putative role for PAR-2, which is activated by cowhage, in the of CCCA," the authors write. "Future studies should examine PAR-2 directed therapeutics for CCCA patients. Examining for itch and other dysesthesias in CCCA patients is of vital importance to dermatologists in assessing ."

Explore further: Hair styles may contribute to scarring hair loss in African-American women

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Hair styles may contribute to scarring hair loss in African-American women

April 11, 2011
Hair grooming practices, such as braids and weaves, as well as inflammation in the form of bacterial infection, may be contributing to the development of scarring hair loss in African American women, according to a report ...

Study looks at effect of emotions on pain and itch intensity

March 16, 2012
(HealthDay) -- Emotions influence the experience of somatosensory sensations of both pain and itch, with negative emotions eliciting higher levels of itch and pain compared to positive emotions, according to research published ...

Body location plays part in scratching pleasure

January 27, 2012
An itch is just an itch. Or is it? New research from Gil Yosipovitch, M.D., Ph.D., professor of dermatology at Wake Forest Baptist Medical Center and a world-renowned itch expert, shows that how good scratching an itch feels ...

Pain and itch connected down deep

May 2, 2011
A new study of itch adds to growing evidence that the chemical signals that make us want to scratch are the same signals that make us wince in pain.

Styling practices can lead to serious hair and scalp diseases for African-Americans

March 19, 2012
Styling practices can lead to serious hair and scalp diseases for some African Americans, says Henry Ford Hospital dermatologist Diane Jackson-Richards, M.D.

Vitamin D influences racial differences in breast cancer risk

April 4, 2012
American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer. There continues to be discussion about the role of low levels of vitamin D in the development ...

Recommended for you

Poliovirus therapy induces immune responses against cancer

September 20, 2017
An investigational therapy using modified poliovirus to attack cancer tumors appears to unleash the body's own capacity to fight malignancies by activating an inflammation process that counter's the ability of cancer cells ...

Scientists restore tumor-fighting structure to mutated breast cancer proteins

September 20, 2017
Scientists at the Virginia Tech Carilion Research Institute have successfully determined the full architecture of the breast cancer susceptibility protein (BRCA1) for the first time. This three-dimensional information provides ...

Brain cancer growth halted by absence of protein, study finds

September 20, 2017
The growth of certain aggressive brain tumors can be halted by cutting off their access to a signaling molecule produced by the brain's nerve cells, according to a new study by researchers at the Stanford University School ...

New clinical trial explores combining immunotherapy and radiation for sarcoma patients

September 20, 2017
University of Maryland School of Medicine researchers are investigating a new approach to treat high-risk soft-tissue sarcomas by combining two immunotherapy drugs with radiation therapy to stimulate the immune system to ...

Researchers identify new target, develop new drug for cancer therapies

September 20, 2017
Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to ...

Targeted antibiotic use may help cure chronic myeloid leukaemia

September 19, 2017
The antibiotic tigecycline, when used in combination with current treatment, may hold the key to eradicating chronic myeloid leukaemia (CML) cells, according to new research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.